Market News & Trends
Haselmeier Receives Medical Device Master File Number for Product Platform
Haselmeier officially announced it has received Master File Number MAF3202 from the US FDA for its D-Flex product platform, a new generation of injection pen…
Bormioloi Pharma Issues Binding Offer to Acquire GCL Pharma
Bormioli Pharma recently announced the issuing of a Binding Offer for the acquisition of 100% of GCL Pharma, an Italian subsidiary of the Guala Closures…
Catalent Partners With Biohaven on New Fast-Dissolve Treatment
Catalent recently welcomed the announcement by Biohaven Pharmaceutical Holding Company Ltd. that the US FDA has approved its NURTEC ODT (rimegepant) for the acute treatment…
Arcutis Announces Inclusion of Children in On-going Pivotal Phase 3 Clinical Trials
Arcutis Biotherapeutics, Inc. recently announced that, at the request of the US FDA, it has submitted a protocol amendment to the FDA to include children…
Considering a Technology Transfer? Start by Making Sure You Have the Right Partner
Simply put, a technology transfer is the moving of a product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve project realization…..
CERo Therapeutics Announces Research Collaboration With Lyell Immunopharma; Completion of Financing
Under the terms of the agreement, CERo and Lyell will collaborate to pursue proof-of-concept studies for a new class of cell-based therapeutics directed against….
Pfizer & BioNTech to Co-develop Potential COVID-19 Vaccine
Pfizer Inc. and BioNTech SE recently announced the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a….
Exagen Inc. Partners With Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease
Exagen Inc. recently announced it has entered into a strategic partnership with Sonora Quest, the nation’s largest integrated…
Biomerica Begins Shipping Samples of 10-Minute Test for COVID-19 Virus Exposure
Biomerica Inc. recently announced it has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in…..
Evonik Achieves Major Biotech Breakthrough With a New Animal-Free & Fermentation-Based Collagen Platform
Evonik recently announced the development of an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials…..
Tyligand Bioscience & Context Therapeutics Sign Strategic Development Agreement for Onapristone ER
Tyligand Bioscience and Context Therapeutics LLC recently announced the signing of collaboration agreements for the development, manufacturing, registration and future commercialization of….
Nurix Therapeutics Closes $120-Million Financing to Advance Targeted Protein Modulation Drug Pipeline
With the funds raised in this financing, Nurix is well positioned to bring its targeted protein modulation therapeutics into the clinic…..
Zydus & XOMA Announce Exclusive Licensing Agreement
Zydus Cadila and XOMA Corporation recently announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO) drug candidate that….
DEINOVE Passes Second Milestone of the AGIR Program
DEINOVE recently announced it has successfully completed the second key milestone of the AGIR program – Antibiotics against Resistant Infectious Germs – which is supported by……
Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board
Ajinomoto Bio-Pharma Services recently announced the formation of its External Advisory Board (EAB) to provide insight into industry trends and…..
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections, Including COVID-19
BeyondSpring Inc. recently announced the submission of a provisional US patent application for its pipeline asset BPI-002, for methods of treating viral infections, including COVID-19,…
Menlo Therapeutics & Foamix Pharmaceuticals Complete Merger
Menlo Therapeutics Inc. recently announced the completion of its merger with Foamix Pharmaceuticals Ltd. following the satisfaction of all closing conditions required by the merger…
Retrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 Study
Retrophin, Inc. recently announced that the first 190 patients have been enrolled in the pivotal Phase 3 DUPLEX Study evaluating the safety and efficacy of…
10 Drugs in Pre-Registration Phase Have Potential to Reach Blockbuster Status by 2025
Out of all the drugs that are currently in the pre-registration phase and are expected to launch in 2020, 10 have the potential to reach…
Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment & Prevention of Coronavirus Disease
Emergent BioSolutions Inc. recently announced it has initiated development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19). These product candidates…
